Pando Bioscience
Gen-AI Designed Enzymes for Pharmaceutical Innovation
Boston, United States · Founded 2022
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2022
- Website
- pando.bio
- Last Round
- SeedApr 2023
- Rounds
- 1
About
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.
Summary
Pando Bioscience is a Biotech company based in Boston, United States, founded in 2022. Its most recent funding was a Seed round in Apr 2023. Investors include Creative Destruction Lab, Y Combinator and Endless Frontier Labs.
Funding History
Apr 2023
Investors
Similar Companies
Ginkgo Bioworks operates autonomous laboratories that use robotics to run experimental work, help...
Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pando-bioscience"><img src="https://indexed.vc/api/badge/company/pando-bioscience" alt="Pando Bioscience on Indexed.vc" width="260" height="76" /></a>